Join
Live feed
·
PRReleasevia Quantisnow
Eton Pharmaceuticals Inc. logo

Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

ByQuantisnow·Wall Street's wire, on your screen.
ETON· Eton Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ETON (Eton Pharmaceuticals Inc.) and more on Quantisnow.